SmithKline Smoking Cessation Franchise Sales Up 68% In First Quarter
This article was originally published in The Tan Sheet
Executive Summary
Worldwide sales of SmithKline Beecham's smoking cessation business jumped 68% to $183 mil. in the first quarter, the company announced April 20. Building on its dominance in the U.S. with Nicorette and NicoDerm CQ, the company continues efforts to grow the franchise internationally.